Part III: Interactive Tumor Board

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Mara Antonoff, MD
Disclosure(s): BMS, AZ, Merck, Ethicon: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing)

Kiran Lagisetty, MD
Disclosure(s): AtriCure: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Panelists

Ashley E. Prosper, MD
Disclosure(s): Canon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 1, 2024); MedQIA: Consultant (Ongoing)

Scott Oh, DO

Percy Lee, MD
Disclosure(s): AstraZeneca: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Genentech: Consultant (Ongoing); ImmuneSensor: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); Johnson & Johnson: Advisory Board (Ongoing), Consultant (Ongoing); Roche: Consultant (Ongoing); RTOG Foundation: Consultant (Terminated); Varian: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

David Tom Cooke, MD
Disclosure(s): Bristol Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Intuitive Surgical: In kind education support; Food (Ongoing); Oxford University Press: Royalties (Ongoing)

Karen Reckamp, MD
Disclosure(s): AstraZeneca, Blueprint, Boehringer Ingelheim, Daiichi Sankyo, Genentech, GlaxoSmithKline, Janssen, Lilly, Mirati, Novartis, Novocure: Consultant (Terminated, September 11, 2024); Genentech; Blueprint; Daiichi Sankyo; Elevation Oncology; Janssen: research funding to institution (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Presentations

  1. Introduction
    Kiran Lagisetty, MD
    Disclosure(s): AtriCure: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
  2. Case 1 / Discussion
  3. Case 2 / Discussion
  4. Case 3 / Discussion
     
  5. Closing Remarks
    John D. Mitchell, MD
    Disclosure(s): DaVinci Intuitive Surgical: Advisory Board (Ongoing), Consultant (Ongoing)
Activity summary
Available credit: 
  • 0.50 ABS Accredited CME
  • 0.50 ABTS Accredited CME
  • 0.50 AMA PRA Category 1 Credit
Activity opens: 
03/01/2025
Activity expires: 
03/01/2028
Cost:
$0.00
Rating: 
0

Available Credit

  • 0.50 ABS Accredited CME
  • 0.50 ABTS Accredited CME
  • 0.50 AMA PRA Category 1 Credit

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Mara Antonoff, MD
Disclosure(s): BMS, AZ, Merck, Ethicon: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing)

Kiran Lagisetty, MD
Disclosure(s): AtriCure: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Panelists

Ashley E. Prosper, MD
Disclosure(s): Canon: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 1, 2024); MedQIA: Consultant (Ongoing)

Scott Oh, DO

Percy Lee, MD
Disclosure(s): AstraZeneca: Advisory Board (Ongoing), Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Genentech: Consultant (Ongoing); ImmuneSensor: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); Johnson & Johnson: Advisory Board (Ongoing), Consultant (Ongoing); Roche: Consultant (Ongoing); RTOG Foundation: Consultant (Terminated); Varian: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

David Tom Cooke, MD
Disclosure(s): Bristol Myers Squibb: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Intuitive Surgical: In kind education support; Food (Ongoing); Oxford University Press: Royalties (Ongoing)

Karen Reckamp, MD
Disclosure(s): AstraZeneca, Blueprint, Boehringer Ingelheim, Daiichi Sankyo, Genentech, GlaxoSmithKline, Janssen, Lilly, Mirati, Novartis, Novocure: Consultant (Terminated, September 11, 2024); Genentech; Blueprint; Daiichi Sankyo; Elevation Oncology; Janssen: research funding to institution (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Presentations

  1. Introduction
    Kiran Lagisetty, MD
    Disclosure(s): AtriCure: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
  2. Case 1 / Discussion
  3. Case 2 / Discussion
  4. Case 3 / Discussion
     
  5. Closing Remarks
    John D. Mitchell, MD
    Disclosure(s): DaVinci Intuitive Surgical: Advisory Board (Ongoing), Consultant (Ongoing)